NO951147L - Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel - Google Patents
Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddelInfo
- Publication number
- NO951147L NO951147L NO951147A NO951147A NO951147L NO 951147 L NO951147 L NO 951147L NO 951147 A NO951147 A NO 951147A NO 951147 A NO951147 A NO 951147A NO 951147 L NO951147 L NO 951147L
- Authority
- NO
- Norway
- Prior art keywords
- stands
- carboxylic acid
- residue
- drug
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det blir beskrevet substituerte heterocykliske karboksylsyreamidestere med den generelle formel l (D hvor O står for O, S eller NRT, X står for O eller S, Y står for CR3 eller N, m står for O og l , A står for eventuelt substituert (C^-C^ )-alkylen, B står for -C02V, R1 og R3 er Ilke eller forskjellige og står for hydrogen, (Cj-Cgi-alkyl , (Cj-CgJ-alkoksy , halogen, hydroksy, eventuelt substituert amlno, alkylkarbonyloksy , R2 står for en karboksylsyrelsostergruppe, R* står for en forgrenet eller uforgrenet alkylrest, en (C^-CKj-arylrest , en (C- alkylrest, en heteroarylrest eller en heteroaralkyl- rest, eller R1 og R4 kan danne en kjede [CH2]0, en eller to grupper kan være erstattet av et heteroatom. Det er også beskrevet en fremgangsmåte for fremstilling av disse forbindelsene. De nevnte forbindelsene finner deres anvendelse som legemiddel mot flbrotlske sykdommer og som hemmere av prolylhydroksylasen og kollagenblosyntesen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410453A DE4410453A1 (de) | 1994-03-25 | 1994-03-25 | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO951147D0 NO951147D0 (no) | 1995-03-24 |
NO951147L true NO951147L (no) | 1995-09-26 |
Family
ID=6513880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951147A NO951147L (no) | 1994-03-25 | 1995-03-24 | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0673930A1 (no) |
JP (1) | JPH07278111A (no) |
KR (1) | KR950032127A (no) |
AU (1) | AU1504495A (no) |
CA (1) | CA2145473A1 (no) |
CZ (1) | CZ73595A3 (no) |
DE (1) | DE4410453A1 (no) |
FI (1) | FI951388A (no) |
HU (1) | HUT72596A (no) |
NO (1) | NO951147L (no) |
PL (1) | PL307846A1 (no) |
ZA (1) | ZA952410B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0206711D0 (en) | 2002-03-21 | 2002-05-01 | Isis Innovation | HIF Inhibitor |
US8558002B2 (en) | 2006-11-16 | 2013-10-15 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
JP2010510242A (ja) * | 2006-11-16 | 2010-04-02 | アラーガン、インコーポレイテッド | キナーゼ阻害剤としてのスルホキシミン |
KR102336926B1 (ko) | 2014-10-06 | 2021-12-08 | 버텍스 파마슈티칼스 인코포레이티드 | 낭성 섬유증 막횡단 전도도 조절자의 조정제 |
WO2017173274A1 (en) | 2016-03-31 | 2017-10-05 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator |
PL3519401T3 (pl) | 2016-09-30 | 2022-01-31 | Vertex Pharmaceuticals Incorporated | Modulator mukowiscydozowego przezbłonowego regulatora przewodnictwa, kompozycje farmaceutyczne, sposoby leczenia i proces wytwarzania modulatora |
CN110267948B (zh) | 2016-12-09 | 2023-12-08 | 弗特克斯药品有限公司 | 囊性纤维化跨膜传导调控剂的调节剂、药物组合物、治疗方法和制备所述调节剂的方法 |
WO2018227049A1 (en) | 2017-06-08 | 2018-12-13 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
US11517564B2 (en) | 2017-07-17 | 2022-12-06 | Vertex Pharmaceuticals Incorporated | Methods of treatment for cystic fibrosis |
CA3071278A1 (en) | 2017-08-02 | 2019-02-07 | Vertex Pharmaceuticals Incorporated | Processes for preparing pyrrolidine compounds |
IL273831B1 (en) | 2017-10-19 | 2024-06-01 | Vertex Pharma | Crystal forms and preparations of CFTR modulators |
US11465985B2 (en) | 2017-12-08 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Processes for making modulators of cystic fibrosis transmembrane conductance regulator |
TWI810243B (zh) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | 用於治療囊腫纖化症之醫藥組合物 |
EP3774825A1 (en) | 2018-04-13 | 2021-02-17 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410453A patent/DE4410453A1/de not_active Withdrawn
-
1995
- 1995-03-09 EP EP95103405A patent/EP0673930A1/de not_active Withdrawn
- 1995-03-23 CZ CZ95735A patent/CZ73595A3/cs unknown
- 1995-03-23 FI FI951388A patent/FI951388A/fi unknown
- 1995-03-23 AU AU15044/95A patent/AU1504495A/en not_active Abandoned
- 1995-03-24 HU HU9500863A patent/HUT72596A/hu unknown
- 1995-03-24 JP JP7065927A patent/JPH07278111A/ja active Pending
- 1995-03-24 PL PL95307846A patent/PL307846A1/xx unknown
- 1995-03-24 CA CA002145473A patent/CA2145473A1/en not_active Abandoned
- 1995-03-24 NO NO951147A patent/NO951147L/no unknown
- 1995-03-24 ZA ZA952410A patent/ZA952410B/xx unknown
- 1995-03-25 KR KR1019950006806A patent/KR950032127A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL307846A1 (en) | 1995-10-02 |
HUT72596A (en) | 1996-05-28 |
EP0673930A1 (de) | 1995-09-27 |
ZA952410B (en) | 1995-12-01 |
CZ73595A3 (en) | 1995-11-15 |
NO951147D0 (no) | 1995-03-24 |
KR950032127A (ko) | 1995-12-20 |
DE4410453A1 (de) | 1995-09-28 |
FI951388A0 (fi) | 1995-03-23 |
JPH07278111A (ja) | 1995-10-24 |
AU1504495A (en) | 1995-10-05 |
FI951388A (fi) | 1995-09-26 |
CA2145473A1 (en) | 1995-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO951147L (no) | Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel | |
DE59401923D1 (de) | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel | |
PT76316A (en) | Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect | |
ATE149486T1 (de) | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel | |
DK446279A (da) | Fremgangsmaade til fremstilling af substituerede 1-carba-2-penem-3-carboxylsyrer | |
SE8303208D0 (sv) | Heterocykliska foreningar | |
WO2000046198A8 (en) | Anti-inflammatory indole derivatives | |
PT83310A (de) | Heterocyclish substitutierte indole zwischenprodukte verfahren zu ihrer herstellung und arzneimittel | |
DE3167757D1 (en) | Dibenz(b,f)(1,4)oxazepine derivatives, process for preparing the same, and pharmaceutical compositions comprising the same | |
YU16899A (sh) | Aralkil i aralkiliden heterociklicni laktami i imidi | |
ATE302778T1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ES2123652T3 (es) | 7-(2-aminoetil)-benzotiazolonas. | |
AU633408B2 (en) | New imidazo (1,2-c) derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
DE69624582T2 (de) | Ester und amide als pla2-inhibitoren | |
ZA815043B (en) | Diazepine derivatives,process for their preparation,and pharmaceutical compositions thereof | |
US4483861A (en) | Antihypertensive sulfur-containing compounds | |
PT76328B (en) | Process for the preparation of pyridinocarboxylic acids esters having an anti-ischemic and anti-hypoxygenic effect and application thereof for the preparation of pharmaceutical compositions having an anti-ischemic and anti-hypoxygenic effect | |
ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
AU4355696A (en) | Substituted amidinonaphthyl ester derivatives | |
ATE56437T1 (de) | Verfahren zur herstellung von 1,4dihydropyridinderivaten ueber neue zwischenprodukte. | |
NO20020561L (no) | Fremgangsmåte for fremstilling av syrer via alfa-klorepoksi- estere | |
EA200100163A1 (ru) | Новые производные 6-деоксиэритромицина, способ их получения и их применение в качестве лекарственных средств |